. . . . . . . "[Treatment with intraperitoneal recombinant human (rh) ACE2 (2�mg/kg) for 21�days improved survival, exercise capacity, and lung function and decreased lung inflammation and fibrosis in male BLM-WT mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:47+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .